These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10723532)

  • 21. Allergens in hymenoptera venom. IX. Species specificity to Polistes (paper wasp) venoms.
    Hoffman DR; McDonald CA
    Ann Allergy; 1982 Feb; 48(2):82-6. PubMed ID: 7065471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The key role of IgG4 subclass antibodies in the development of protection against allergic reactions to insect stings].
    Urbanek R; Dold S
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):536-40. PubMed ID: 3773921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sting challenge test in Hymenoptera venom allergy: pros and cons.
    Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaphylaxis after Hymenoptera sting without detectable specific IgE.
    Zidarn M; Kosnik M; Drinovec I
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Mar; 16(1):31-3. PubMed ID: 17992452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basophil degranulation test (BDT) as a parameter of hyposensitization with Hymenoptera venoms].
    Dietschi R; Wüthrich B; Marti-Wyss S; Cuhat J
    Schweiz Med Wochenschr; 1987 Oct; 117(44):1728-35. PubMed ID: 3685930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM; Van Hoeyveld EM; Stevens EA
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyper-accelerated immunotherapy with Hymenoptera venoms].
    Sabbah A; Bonneau JC; Drouet M; Le Sellin J
    Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The wasp/mosquito syndrome].
    Sabbah A; Hassoun S; Drouet M; Lauret MG; Doucet M
    Allerg Immunol (Paris); 1999 Jun; 31(6):175-84. PubMed ID: 10443298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stinging insect allergy and venom immunotherapy.
    Gupta P; Greenberger PA
    Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
    [No Abstract]   [Full Text] [Related]  

  • 33. Alternating Polistes-Vespula venom immunotherapy: a therapeutic strategy to resolve a diagnostic deficiency.
    Moreno C; Barasona MJ; Serrano P; Justicia JL; Ruz JM; Guerra F
    J Investig Allergol Clin Immunol; 2011; 21(1):28-33. PubMed ID: 21370720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
    Ring J; Lonsdorf G; Schury W; Burg G
    MMW Munch Med Wochenschr; 1982 Jun; 124(24):587-90. PubMed ID: 6810134
    [No Abstract]   [Full Text] [Related]  

  • 35. A controlled trial of immunotherapy in insect hypersensitivity.
    Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
    N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of Hymenoptera venom allergy in Eastern Spain.
    Fernandez J; Soriano V; Mayorga L; Mayor M
    Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgE antibodies to Hymenoptera venoms in the serum are common in the general population and are related to indications of atopy.
    Schäfer T; Przybilla B
    Allergy; 1996 Jun; 51(6):372-7. PubMed ID: 8837658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of rush immunotherapy (RIT) on Hymenoptera allergy].
    Hirata H; Yukawa T; Arima M; Yamada G; Makino S; Fukuda T
    Arerugi; 1999 Dec; 48(12):1331-6. PubMed ID: 10666921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
    Wüthrich B; Arrendal H; Lanner A
    Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
    Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
    Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.